Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 8, Issue:3, March, 2019

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(3): 1253-1257
DOI: https://doi.org/10.20546/ijcmas.2019.803.148


Susceptibility Pattern of Enterococcal Isolates in a Tertiary Care Hospital against Tigecycline, Linezolid and Teicoplanin
Ashina Singla*, Ayushi Sharma and Ved Prakash Mamoria
Department of Microbiology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, India
*Corresponding author
Abstract:

There has been an upsurge in the emergence of Enterococci as a nosocomial pathogen in the recent years. The emergence of vancomycin-resistant enterococci (VRE) is a cause of concern, and is very difficult to control. A study on the speciation and antimicrobial susceptibility pattern of Linezolid, Teicoplanin and Tigecycline isolated of from clinical specimens from patients in the Department of Microbiology, MGUMST was carried out in the period of January 2018 to December 2018. A total of 172 enterococcal isolates obtained from various clinical samples were included in the study. Identification and antimicrobial susceptibility testing was done on Vitek-2 Compact (bioMérieux) E. facealis (54.97%) was the predominant enterococcal species isolated followed by E. faecium (39.76%). The isolates were shown to have 5.84% resistance to Linezolid, 13.45% resistance to Teicoplanin and 100% sensitivity to Tigecycline. This study was performed to seek an alternative option like Linezolid, Tigecycline and Teicoplanin as vancomycin is reportedly being noted resistant in many clinical cases.


Keywords: Enterococcus, Susceptibility, Tigecycline, Resistance, Linezolid, Teicoplanin

Download this article as Download

How to cite this article:

Ashina Singla, Ayushi Sharma and Ved Prakash Mamoria. 2019. Susceptibility Pattern of Enterococcal Isolates in a Tertiary Care Hospital against Tigecycline, Linezolid and Teicoplanin.Int.J.Curr.Microbiol.App.Sci. 8(3): 1253-1257. doi: https://doi.org/10.20546/ijcmas.2019.803.148
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations